Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Syrosingopine is an inhibitor of monocarboxylate transporter 1 (MCT1) and MCT4 (IC50s = 2,500 and 40 nM, respectively).1 It inhibits MCT-facilitated lactate export and decreases intracellular pH in HL-60 promyeloblast cells when used at a concentration of 10 µM. Syrosingopine (5 µM), in combination with metformin (Item No. 13118), decreases cell growth in HL-60 cells.2 Intravenous administration of syrosingopine (0.5 mg/kg) reduces heart norepinephrine levels, mean arterial pressure (MAP), and pulse rate in normotensive dogs.3 Formulations containing syrosingopine have been used in the treatment of hypertension.
WARNING This product is not for human or veterinary use.
1. Dual inhibition of the lactate transporters MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion in cancer cells. Cell Rep. 25(11), 3047-3058 (2018).
2. Syrosingopine sensitizes cancer cells to killing by metformin. Sci. Adv. 2(12), e1601756 (2016).
3. Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118). J. Pharmacol. Exp. Ther. 128, 131-139 (1960).